## Review setup

- **Input scope** Abstract only
- **Assessment boundary** Claims and conclusions as presented in the abstract; no access to full methods, figures, tables, or supplementary materials
- **Shared manuscript claim summary** The authors propose that TCDD exposure induces non-obstructive azoospermia through specific molecular pathways, identify five hub genes via machine learning and network toxicology, and validate binding of TCDD to AR through biomolecular modeling, with implications for diagnosis and therapy
- **Visible evidence base** Abstract text only; no numerical data beyond those cited in the abstract; no methodological details; no figures or tables
- **Missing materials affecting confidence** Full manuscript, methods section, all figures and tables, supplementary data, statistical analysis details, model validation procedures, single-cell analysis parameters, and biomolecular modeling protocols

## Reviewer

- **Overall assessment** The abstract presents a potentially interesting integrative bioinformatics approach to link TCDD exposure with NOA pathogenesis. However, the evidence provided is insufficient to evaluate the robustness of the findings. The study relies heavily on computational predictions and secondary data analyses, and the abstract does not provide enough detail to assess the validity of the machine learning models, the biological relevance of the identified hub genes, or the significance of the molecular docking results. The causal claim implied by the title is not supported by the evidence presented, which is largely correlative and computational.
- **Who would be interested in the results, and why** Researchers in environmental toxicology, reproductive biology, and male infertility may find the proposed molecular links between TCDD and NOA of interest. Those working on biomarker discovery for azoospermia and on computational approaches to toxicology could also be engaged. However, the clinical and translational relevance remains speculative without experimental validation.
- **Major strengths** The study integrates multiple computational methods, including ssGSEA, WGCNA, machine learning, and single-cell analysis, which is methodologically ambitious. The identification of five hub genes with reported AUC values above 0.7 suggests some predictive capacity. The focus on a specific NOA subtype, SCOS, adds granularity. The molecular docking analysis provides a preliminary biophysical interaction assessment.
- **Major Concerns**  
  - R1-M1  
  - R1-M2  
  - R1-M3  
  - R1-M4  
  - R1-M5
- **Minor Comments**  
  - R1-m1  
  - R1-m2  
  - R1-m3  
  - R1-m4
- **Technical failings that need to be addressed before the case is established** R1-M1, R1-M2, R1-M3, R1-M4, R1-M5
- **Assessment against Nature-style criteria**  
  - Originality: Moderate. The combination of network toxicology and machine learning is not entirely novel, though the specific application to TCDD and NOA may offer some new angles.  
  - Scientific importance: Potentially relevant to environmental health and male infertility, but the current evidence does not establish a definitive mechanistic link.  
  - Interdisciplinary readership: The topic bridges toxicology, bioinformatics, and reproductive medicine, which could attract a broad audience if the findings are robust.  
  - Technical soundness: Cannot be fully assessed from the abstract. The lack of methodological detail and validation undermines confidence.  
  - Readability for nonspecialists: The abstract is dense with acronyms and technical terms, which may limit accessibility. A clearer narrative of the biological rationale and implications would improve readability.
- **Recommendation posture** Currently not established from the provided evidence. The abstract alone does not provide sufficient support for the causal and translational claims. A revised manuscript with full methodological transparency, experimental validation, and clearer presentation of results would be required for a supportive posture.

### Major Concerns

- **Concern ID** R1-M1  
- **Severity** Major  
- **Blocking** Yes  
- **Axis** Causal inference  
- **Claim pointer** The title and conclusions state that TCDD "induces" NOA and that the study reveals "potential molecular mechanisms" of this induction.  
- **Evidence pointer** Abstract, Objective and Conclusions sections  
- **Concern** The abstract presents correlative and computational findings but does not provide experimental evidence of causation. The claim that TCDD induces NOA is presented as established, yet the data are derived from bioinformatics analyses and molecular docking, which cannot demonstrate a causal relationship.  
- **Why it matters** A causal claim has significant public health and regulatory implications. Without experimental validation, such as in vitro or in vivo exposure models, the conclusion overreaches the evidence.  
- **Resolution test** Provide experimental data showing that TCDD exposure leads to NOA phenotypes in model systems, or temper the language to reflect association and prediction rather than causation.

- **Concern ID** R1-M2  
- **Severity** Major  
- **Blocking** Yes  
- **Axis** Methodological transparency  
- **Claim pointer** The abstract states that a diagnostic model was constructed based on 113 machine learning algorithms and that five hub genes were identified with AUC > 0.7.  
- **Evidence pointer** Abstract, Methods section  
- **Concern** No details are provided on the datasets used, the training and validation procedures, the handling of class imbalance, or the criteria for selecting the final model among 113 algorithms. The AUC values are reported without confidence intervals or external validation.  
- **Why it matters** Machine learning models are prone to overfitting, and without rigorous validation, the reported performance metrics may not generalize. The lack of transparency prevents assessment of model reliability.  
- **Resolution test** Describe the datasets, feature selection, cross-validation scheme, and external validation results. Report confidence intervals and calibration metrics for the AUC values.

- **Concern ID** R1-M3  
- **Severity** Major  
- **Blocking** Yes  
- **Axis** Biological plausibility  
- **Claim pointer** The abstract claims that AR and DDR2 are specifically expressed in testicular tissues of NOA patients and are closely associated with SCOS.  
- **Evidence pointer** Abstract, Results section  
- **Concern** The abstract does not specify the source of the testicular tissue data, the sample size, or the statistical methods used to determine specificity. The claim of "specific expression" is strong and requires careful comparison with appropriate controls, including other NOA subtypes and normal tissues.  
- **Why it matters** Specificity claims are central to the proposed diagnostic utility. If the expression pattern is not truly specific, the translational value is diminished.  
- **Resolution test** Provide detailed information on the tissue cohorts, including sample numbers, clinical characteristics, and statistical comparisons. Show that the expression is specific relative to relevant controls.

- **Concern ID** R1-M4  
- **Severity** Major  
- **Blocking** Yes  
- **Axis** Molecular docking validity  
- **Claim pointer** The abstract states that biomolecular modeling demonstrated strong binding affinity between AR and TCDD with ∆G = -8.3 kcal/mol and E(total) = -37.79 kcal/mol.  
- **Evidence pointer** Abstract, Results section  
- **Concern** The binding energy values are presented without context regarding the docking software, scoring functions, or validation of the docking protocol. The biological relevance of these values is unclear, and no comparison with known ligands or negative controls is provided.  
- **Why it matters** Molecular docking results are highly dependent on the methodology and can produce false positives. Without proper validation, the claim of strong binding is not substantiated.  
- **Resolution test** Describe the docking protocol, include validation against known AR ligands, and provide statistical measures of confidence. Discuss the limitations of the approach.

- **Concern ID** R1-M5  
- **Severity** Major  
- **Blocking** Yes  
- **Axis** Immune infiltration interpretation  
- **Claim pointer** The abstract claims that TCDD induces abnormal infiltration of various immune cells, indicating a close relationship with immune inflammatory responses.  
- **Evidence pointer** Abstract, Results section  
- **Concern** The abstract does not specify which immune cell types were analyzed, the method used to infer infiltration, or the direction of the changes. The causal language "induces" is not supported by the data, which are likely derived from computational deconvolution of bulk transcriptomic data.  
- **Why it matters** Immune infiltration inferences are indirect and can be confounded by tissue composition and technical artifacts. Overinterpretation could mislead subsequent research.  
- **Resolution test** Specify the immune cell types, the deconvolution method, and the statistical significance. Use cautious language such as "associated with" rather than "induces."

### Minor Comments

- **Concern ID** R1-m1  
- **Severity** Minor  
- **Axis** Clarity  
- **Affected element** Abstract, Objective section  
- **Evidence pointer** Abstract text  
- **Issue** The phrase "global male semen quality has been declining at a rate of 2.64 % per year in the 21st century" is presented without citation or context. This statistic may be contested and requires a reference.  
- **Required correction** Add a citation and briefly contextualize the statistic.

- **Concern ID** R1-m2  
- **Severity** Minor  
- **Axis** Terminology  
- **Affected element** Abstract, Methods section  
- **Evidence pointer** Abstract text  
- **Issue** The term "single-sample Gene Set Enrichment Analysis (ssGSEA)" is used, but the abstract does not clarify whether this was applied to bulk RNA-seq or microarray data.  
- **Required correction** Specify the data type used for ssGSEA.

- **Concern ID** R1-m3  
- **Severity** Minor  
- **Axis** Reporting completeness  
- **Affected element** Abstract, Results section  
- **Evidence pointer** Abstract text  
- **Issue** The p-values for the association of AR and DDR2 with SCOS are reported as p < 0.05, but the statistical test used is not stated.  
- **Required correction** Indicate the statistical test and whether multiple testing corrections were applied.

- **Concern ID** R1-m4  
- **Severity** Minor  
- **Axis** Language precision  
- **Affected element** Abstract, Conclusions section  
- **Evidence pointer** Abstract text  
- **Issue** The phrase "providing new targets for the development of diagnostic and therapeutic strategies" is speculative and not supported by the evidence presented.  
- **Required correction** Rephrase to indicate that the findings may inform future research directions, rather than implying immediate clinical applicability.

## Risk / unsupported claims

- The causal claim that TCDD "induces" NOA is unsupported by the evidence presented, which is computational and correlative.
- The claim of "strong binding affinity" between AR and TCDD is not substantiated without validation of the docking methodology.
- The assertion that immune infiltration abnormalities are "induced" by TCDD is not supported by the data.
- The diagnostic utility of the five hub genes is not established without external validation and clinical context.
- The specificity of AR and DDR2 expression in NOA testicular tissues is not verifiable from the abstract alone.